Pharmacotherapy considerations in transgender individuals living with human immunodeficiency virus

Pharmacotherapy considerations are often a concern for transgender individuals who are living with human immunodeficiency virus (HIV) due to concerns for drug–drug interactions between their hormone and antiretroviral therapies. Many of the first‐line therapies offered to patients for the management...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Pharmacotherapy 2021-03, Vol.41 (3), p.299-314
Hauptverfasser:	Badowski, Melissa E., Britt, Nicholas, Huesgen, Emily C., Lewis, Michelle M., Miller, Misty M., Nowak, Kathleen, Sherman, Elizabeth, Smith, Renata O.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiretroviral drugs antiretroviral therapy Drug Interactions Drug therapy Female HIV HIV Infections - drug therapy hormone therapy Human immunodeficiency virus Humans Male Transgender Persons
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!